Could Opportunity for Takeda's Subcutaneous Entyvio Diminish by the Time It Reaches Its Now Projected 2023 US Approval? Spherix Investigates
/PRNewswire/ -- In their most recent earnings call on October 29, 2021, Takeda revealed that discussions with the FDA have led to a potential approval for...